<DOC>
	<DOCNO>NCT03097315</DOCNO>
	<brief_summary>Open-label safety study suprachoroidal triamcinolone acetone injectable suspension patient non-infectious uveitis .</brief_summary>
	<brief_title>Suprachoroidal Injection CLS-TA Subjects Non-infectious Uveitis</brief_title>
	<detailed_description>This Phase 3 , open-label , multi-center study ass safety 4 mg CLS-TA administer via suprachoroidal injection treatment subject non-infectious uveitis .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Panuveitis</mesh_term>
	<mesh_term>Uveitis , Posterior</mesh_term>
	<mesh_term>Uveitis , Intermediate</mesh_term>
	<mesh_term>Pars Planitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Diagnosis noninfectious uveitis ( pan , anterior , intermediate posterior ) ETDRS BCVA score â‰¥ 5 letter read study eye Any active ocular disease infection study eye uveitis Intraocular pressure &gt; 22 mmHg uncontrolled glaucoma study eye Any uncontrolled systemic disease , opinion Investigator , would preclude participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>UME</keyword>
	<keyword>Posterior Uveitis</keyword>
	<keyword>Anterior Uveitis</keyword>
	<keyword>Intermediate Uveitis</keyword>
	<keyword>Panuveitis</keyword>
	<keyword>Non-infectious Uveitis</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Choroid</keyword>
	<keyword>Choroidal Injection</keyword>
	<keyword>Suprachoroidal</keyword>
	<keyword>Microneedle</keyword>
	<keyword>Microinjection</keyword>
</DOC>